Latest Insider Transactions at Moderna, Inc. (MRNA)
This section provides a real-time view of insider transactions for Moderna, Inc. (MRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moderna, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moderna, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 02
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.61%
|
$0
$0.99 P/Share
|
|
Feb 01
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-29.26%
|
$815,000
$163.67 P/Share
|
|
Feb 01
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Feb 01
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$860,000
$172.99 P/Share
|
|
Feb 01
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jan 29
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.41%
|
$1,933,050
$175.12 P/Share
|
|
Jan 28
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,540,000
$154.11 P/Share
|
|
Jan 27
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Jan 27
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,359,000
$151.27 P/Share
|
|
Jan 25
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$690,000
$138.77 P/Share
|
|
Jan 25
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jan 25
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-0.15%
|
$2,840,000
$142.97 P/Share
|
|
Jan 25
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.6%
|
$0
$0.99 P/Share
|
|
Jan 25
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-35.95%
|
$710,000
$142.51 P/Share
|
|
Jan 25
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jan 24
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.31%
|
$1,365,000
$273.01 P/Share
|
|
Jan 24
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.31%
|
$50,000
$10.9 P/Share
|
|
Jan 22
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.9%
|
$1,458,072
$132.13 P/Share
|
|
Jan 21
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,250,000
$125.28 P/Share
|
|
Jan 20
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Jan 20
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,116,000
$124.51 P/Share
|
|
Jan 19
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$605,000
$121.88 P/Share
|
|
Jan 19
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jan 19
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-46.93%
|
$615,000
$123.63 P/Share
|
|
Jan 19
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jan 15
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.85%
|
$1,435,980
$130.14 P/Share
|
|
Jan 14
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,220,000
$122.83 P/Share
|
|
Jan 13
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.08%
|
$1,230,000
$123.7 P/Share
|
|
Jan 13
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.91%
|
$1,845,000
$123.7 P/Share
|
|
Jan 13
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.6%
|
$0
$0.99 P/Share
|
|
Jan 12
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.3%
|
$585,000
$117.5 P/Share
|
|
Jan 11
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-42.03%
|
$580,000
$116.56 P/Share
|
|
Jan 11
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jan 11
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$560,000
$112.83 P/Share
|
|
Jan 11
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jan 08
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.81%
|
$1,259,244
$114.72 P/Share
|
|
Jan 07
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,200,000
$120.0 P/Share
|
|
Jan 06
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Jan 06
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$990,000
$110.96 P/Share
|
|
Jan 04
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.51%
|
$1,192,968
$108.55 P/Share
|
|
Jan 04
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-1.2%
|
$2,140,000
$107.15 P/Share
|
|
Jan 04
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+0.6%
|
$0
$0.99 P/Share
|
|
Jan 04
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-42.24%
|
$540,000
$108.7 P/Share
|
|
Jan 04
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jan 04
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$535,000
$107.15 P/Share
|
|
Jan 04
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Dec 31
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,100,000
$110.55 P/Share
|
|
Dec 30
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Dec 30
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,062,000
$118.27 P/Share
|
|
Dec 29
2020
|
Stephen Hoge President |
SELL
Bona fide gift
|
Direct |
70,000
-4.07%
|
-
|